Does HLA-DQ8 confer genetic susceptibility to celiac disease?

The genetic architecture of celiac disease is primarily defined by the Human Leukocyte Antigen (HLA) system. Specifically, the presence of HLA-DQ8 (encoded by the DQA1*03 and DQB1*03:02 alleles) is a well-established requirement for the development of the disease in a significant subset of the population.

Clinical evidence

• Presence in affected individuals: HLA-DQ8 is found in approximately 5% to 10% of celiac patients globally. In specific populations, such as those of Mexican or Amerindian descent, its prevalence among patients can be significantly higher, sometimes exceeding 80%.
• Negative predictive value: The absence of both HLA-DQ2 and HLA-DQ8 has a negative predictive value of >99%. This means that if an individual does not carry either allele, the diagnosis of celiac disease can be effectively ruled out.
• Susceptibility vs. Development: While these alleles are necessary for the disease, they are not sufficient. Approximately 30-40% of the general population carries DQ2 or DQ8, but only about 3% of those carriers will develop celiac disease, indicating that other genetic and environmental factors are required for disease manifestation.

Mechanistic explanations

• Peptide binding: The HLA-DQ8 molecule features a specific binding groove that has a high affinity for negatively charged amino acids.
• Deamidation: The enzyme transglutaminase 2 (TG2) modifies gluten-derived gliadin peptides through deamidation, converting neutral glutamine residues into negatively charged glutamate.
• T-cell activation: This modification allows the gluten peptides to bind tightly to the HLA-DQ8 receptor on antigen-presenting cells. These complexes are then recognized by gluten-specific CD4+ T cells, triggering an inflammatory cytokine cascade that leads to the characteristic destruction of the intestinal villi (villous atrophy).

Bottom line

HLA-DQ8 is a critical genetic susceptibility factor for celiac disease. While less common than HLA-DQ2 in European populations, it is a primary driver of the disease in other ethnic groups and serves as a essential diagnostic marker with a near-100% negative predictive value.